Cargando…

Validation for models for tumor recurrence after liver transplantation in hepatectomy patients

PURPOSE: Early recurrence of hepatocellular carcinoma (HCC) remains a challenging issue after hepatic resection (HR) because of the associated poor prognosis. Models for tumor recurrence after liver transplantation (MoRAL) have been designed to predict tumor recurrence in HCC patients in the liver t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sung Joon, Kim, Jong Man, Yi, Nam-Joon, Choi, Gyu-Seong, Lee, Kwang-Woong, Suh, Kyung-Suk, Joh, Jae-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Surgical Society 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914523/ https://www.ncbi.nlm.nih.gov/pubmed/35317356 http://dx.doi.org/10.4174/astr.2022.102.3.131

Ejemplares similares

Living donor liver transplantation should be cautiously considered as initial treatment in recurrent hepatocellular carcinoma within the Milan criteria after curative liver resection
por: Kim, Jong Man, et al.
Publicado: (2020)

Clinical impact of the treatment modality on small, solitary, recurrent intrahepatic hepatocellular carcinomas after primary liver resection
por: Kim, Hyo-Sin, et al.
Publicado: (2021)

Early disseminated recurrence after liver resection in solitary hepatocellular carcinoma
por: Kim, Jong Man, et al.
Publicado: (2018)

Use of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea: 2-center experience
por: Kim, Jong Man, et al.
Publicado: (2018)

Outcomes for patients with HCV after liver transplantation in Korea: a multicenter study
por: Kim, Jong Man, et al.
Publicado: (2016)

Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection
por: Kim, Jong Man, et al.
Publicado: (2016)

Novel Model to Predict HCC Recurrence after Liver Transplantation Obtained Using Deep Learning: A Multicenter Study
por: Nam, Joon Yeul, et al.
Publicado: (2020)

Peri-Transplant Change in AFP Level: a Useful Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation
por: Yoo, Tae, et al.
Publicado: (2016)

Protrusion of hepatocellular carcinoma is a predictor of early recurrence in hepatectomy patients after spontaneous rupture
por: Han, Seung Rim, et al.
Publicado: (2016)

Indications for open hepatectomy in the era of laparoscopic liver resection: a high volume single institutional study
por: Jo, Sung Jun, et al.
Publicado: (2022)

Postoperative Health Status and Quality of Life After Pure Laparoscopic Donor Hepatectomy for Living Donor Liver Transplantation
por: Cho, Chan Woo, et al.
Publicado: (2022)

Increased survival in hepatitis c patients who underwent living donor liver transplant: a case-control study with propensity score matching
por: Kim, Jong Man, et al.
Publicado: (2017)

Tailored Prediction Model of Survival after Liver Transplantation for Hepatocellular Carcinoma
por: Jamtani, Indah, et al.
Publicado: (2021)

Response-Guided Therapy for Hepatitis C Virus Recurrence Based on Early Protocol Biopsy after Liver Transplantation
por: Kim, Hyeyoung, et al.
Publicado: (2015)

Effect of CYP3A5 on the Once-Daily Tacrolimus Conversion in Stable Liver Transplant Patients
por: Kim, Jong Man, et al.
Publicado: (2020)

Risk factors for poor survival after recurrence of hepatocellular carcinoma after liver transplantation
por: Kim, Minjeong, et al.
Publicado: (2021)

LigaSure versus monopolar cautery for recipient hepatectomy in liver transplantation: a propensity score-matched analysis
por: Lee, Jeong-Moo, et al.
Publicado: (2021)

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation
por: Lee, Okjoo, et al.
Publicado: (2022)

Influence of Body Mass Index ≥30 on Pure Laparoscopic Donor Right Hepatectomy
por: Hong, Suk Kyun, et al.
Publicado: (2020)

Pure laparoscopic right hepatectomy in a patient with situs inversus totalis: A case report
por: Hong, Suk Kyun, et al.
Publicado: (2017)

Prognosis of Hepatocellular Carcinoma after Liver Transplantation: Comparative Analysis with Partial Hepatectomy
por: Lee, Kyuho, et al.
Publicado: (2017)

Risk Factors for the Adverse Events after Conversion from Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplantation Patients
por: Suh, Suk-Won, et al.
Publicado: (2016)

Impact of Graft Weight Change During Perfusion on Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation
por: Kim, Jong Man, et al.
Publicado: (2021)

Comparison of Models for Tumor Recurrence after Liver Transplantation for the Patients with Hepatocellular Carcinoma: A Multicenter Long-Term Follow-Up Study
por: Chang, Young, et al.
Publicado: (2019)

Optimal Tailored Screening Protocol after Living Donor Liver Transplantation for Hepatocellular Carcinoma
por: Park, Min-Su, et al.
Publicado: (2014)

Pediatric Liver Transplantation Outcomes in Korea
por: Kim, Jong Man, et al.
Publicado: (2013)

Pure Laparoscopic Versus Open Right Hepatectomy in Living Liver Donors: Graft Weight Discrepancy
por: Seo, Jiwon, et al.
Publicado: (2022)

Intraoperative Ultrasonography as a Guidance for Dividing Bile Duct During Laparoscopic Living Donor Hepatectomy
por: Rhu, Jinsoo, et al.
Publicado: (2019)

Prognosis of preoperative positron emission tomography uptake in hepatectomy patients
por: Kim, Jong Man, et al.
Publicado: (2018)

Generic Tacrolimus (Tacrobell(®)) Shows Comparable Outcomes to Brand-Name Tacrolimus in the Long-Term Period After Adult Deceased Donor Liver Transplantation
por: Kim, Jong Man, et al.
Publicado: (2019)

Postoperative outcomes of purely laparoscopic donor hepatectomy compared to open living donor hepatectomy: a preliminary observational study
por: Bang, Yu Jeong, et al.
Publicado: (2021)

Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence
por: Kang, Seong Hee, et al.
Publicado: (2018)

Pure Laparoscopic vs. Open Right Hepatectomy in Living Liver Donors: Bench-Surgery Time
por: Hong, Kwangpyo, et al.
Publicado: (2021)

Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation
por: Lee, Ju-Yeun, et al.
Publicado: (2014)

Comparative Peripheral Blood T Cells Analysis Between Adult Deceased Donor Liver Transplantation (DDLT) and Living Donor Liver Transplantation (LDLT)
por: Kim, Jong Man, et al.
Publicado: (2017)

A multicenter experience with generic mycophenolate mofetil conversion in stable liver transplant recipients
por: Kim, Jong Man, et al.
Publicado: (2014)

Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival
por: Rhu, Jinsoo, et al.
Publicado: (2018)

Hepatectomy outcomes in patients with hepatitis C virus-related hepatocellular carcinoma with or without cirrhosis
por: Kim, Jong Man, et al.
Publicado: (2022)

Fibrosis-4 index, a predictor for prognosis of hepatocellular carcinoma patients after curative hepatectomy even in hepatitis B virus dominant populations
por: Yun, Sang Oh, et al.
Publicado: (2023)

Pure laparoscopic versus open right donor hepatectomy including the middle hepatic vein: a comparison of outcomes and safety
por: Park, Jae Hyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cbk9onhv9634sqhaqlpln4klg0